Author:
Lu Jing,Lu Dong,Fu Zunyun,Zheng Mingyue,Luo Xiaomin
Reference109 articles.
1. CMR International 2010 Global R&D Performance Metrics Programme. http://cmr.thomsonreuters.com/services/programs/randd/
2. Lasser KE, Allen PD, Woolhandler SJ, Himmelstein DU, Wolfe SM, Bor DH (2002) Timing of new black box warnings and withdrawals for prescription medications. JAMA 287(17):2215–2220. https://doi.org/10.1001/jama.287.17.2215
3. O’Brien SE, de Groot MJ (2005) Greater than the sum of its parts: combining models for useful ADMET prediction. J Med Chem 48(4):1287
4. Vanderwall DE, Yuen N, Al-Ansari M, Bailey J, Fram D, Green DV, Pickett S, Vitulli G, Luengo JI, Almenoff JS (2011) Molecular clinical safety intelligence: a system for bridging clinically focused safety knowledge to early-stage drug discovery - the GSK experience. Drug Discov Today 16(15–16):646–653. https://doi.org/10.1016/j.drudis.2011.05.001 . S1359-6446(11)00143-7 [pii]
5. Accelrys Toxicity Database 2011.4. Accelrys Software Inc., San Diego, CA
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献